Search results
FDA panel votes against ecstasy for PTSD
Axios· 2 hours agoIt's a big setback for the effort to mainstream psychedelic drugs.
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
Pittsburgh Tribune-Review· 8 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 30 minutes agoLykos Therapeutics Provides Update on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD PR Newswire SAN JOSE, Calif., June 4, 2024 SAN JOSE ...
‘Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide’ Review: The Noble Bureaucrat
The Wall Street Journal· 8 hours agoFrances Oldham Kelsey faced a tough choice between two job offers at different federal agencies in...
Denali, Neurogene and more picked by FDA's 'Operation Warp Speed' for rare disease
FierceBiotech· 6 hours agoThe FDA’s “Operation Warp Speed” equivalent for rare disease will include programs from Denali...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
WSB Radio· 8 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
FDA panel to evaluate psychedelic MDMA for treatment of PTSD for first time
Fox News· 10 hours agoA panel of advisers to the U.S. Food and Drug Administration will meet to discuss a therapy based on...
FDA sets panel review for IceCure's breast cancer treatment By Investing.com
Investing.com· 9 hours agoThe U.S. Food and Drug Administration (FDA) is set to convene a Medical Device Advisory Committee...
FDA panel rejects first MDMA treatment amid deep concerns about flawed trials
AOL· 2 hours agoThe two votes — one for the treatment’s efficacy and one for its safety, by the agency’s Psychopharmacologic Drugs Advisory Committee — marked the first time that FDA advisers ...
Exclusive: Former FDA official violated ethics rules by soliciting gifts from activists, watchdog...
BizPac Review· 11 hours agoProtect the Public’s Trust’s (PPT) complaint highlights emails showing that Kathy Crosby, who served in a high-level communications role at the FDA’s Center for Tobacco Products ...
